Does cetirizine (antihistamine) have any role in treating rhinorrhea and cough in children under 2 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cetirizine for Rhinorrhea and Cough in Children Under 2 Years

Cetirizine should not be used for treating rhinorrhea and cough in children under 2 years of age due to lack of established efficacy for these symptoms and potential safety concerns.

Safety Considerations

  • The FDA labeling for cetirizine indicates it is approved for children 6 years and older, not for children under 2 years 1
  • While second-generation antihistamines like cetirizine have been shown to have a better safety profile than first-generation antihistamines in young children, they are still not recommended for treating symptoms of upper respiratory tract infections in children under 2 years 2
  • The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended that OTC medications used to treat cough and cold no longer be used for children below 6 years of age 2
  • Adverse events have been reported with antihistamine use in young children, including insomnia in a 23-month-old child taking cetirizine 3

Efficacy Considerations

  • Controlled trials have shown that antihistamine products are not effective for symptoms of upper respiratory tract infections in young children 2
  • The Cochrane review on anti-histamines for prolonged non-specific cough in children found uncertain efficacy, similar to findings for acute cough 4
  • While cetirizine is licensed in Europe for children older than 2 years and in the USA for children older than 6 months for allergic rhinitis and chronic urticaria, this does not extend to treating rhinorrhea and cough due to upper respiratory infections 5

Alternative Approaches

  • Intranasal corticosteroids are the most effective medication class for controlling symptoms of allergic rhinitis, but their use in children under 2 years should be carefully considered 2
  • For rhinorrhea and cough due to upper respiratory infections in children under 2 years, supportive care measures are preferred over medication 2
  • If allergic rhinitis is suspected as the underlying cause of symptoms in children approaching 2 years of age, consultation with a pediatric allergist may be warranted before considering any medication 6

Clinical Decision Making

  • Distinguish between infectious and allergic causes of rhinorrhea, as treatment approaches differ 2
  • For infectious causes in children under 2 years, focus on supportive care rather than medications 2
  • For allergic causes in children approaching 2 years, cetirizine might be considered only after careful evaluation by a specialist, weighing potential benefits against risks 5
  • Monitor closely for adverse effects if any medication is used in this age group 6, 3

Key Warnings

  • Between 1969 and 2006, there were 69 fatalities associated with antihistamines contained in OTC and prescription agents for children under 6 years, with 41 reported in children under 2 years 2
  • Drug overdose and toxicity were common events reported in these cases, often resulting from medication errors, accidental exposures, or use of multiple products 2
  • The risk-benefit ratio does not favor using cetirizine for rhinorrhea and cough in children under 2 years when the cause is a respiratory infection 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anti-histamines for prolonged non-specific cough in children.

The Cochrane database of systematic reviews, 2006

Research

Cetirizine use in childhood: an update of a friendly 30-year drug.

Clinical and molecular allergy : CMA, 2020

Guideline

Nasal Drops in Children and Infants: Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.